leisure time -WSS

leisure time

author：explore 2025-09-06 04:14:21 - browse：9128

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Glen Campbell's doctor discusses his public struggle with Alzheimer's

knowledge

WSS

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

NIH tests clinical research in primary care with $30 million program

My daughter's legacy lives on through her writing, phage therapy

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Cytokinetics CEO stresses company can launch heart drug on its own

Cheap, fast test for Zika and dengue could cost just $1

knowledge

leisure time

Sign up for Morning Rounds

Wikipedia

New air purifier tech could be key to improving indoor air quality

Stephen Quake on the Chan Zuckerberg quest to conquer disease

What does generative AI mean for health care? We asked experts

Military medical care influenced by rank and race, new study finds

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Glen Campbell's doctor discusses his public struggle with Alzheimer's

In age of alternative facts, a scholarly course on calling out crap

Solving academic medical centers' existential crisis

Medical leaders decry Supreme Court decision on affirmative action

When prostate cancer spreads, where it goes matters

explore

STAT Virtual Event: ASCO Recap, Live!

Arc Institute generative AI designs new CRISPR systems

New report analyzes digital physical therapy solutions' effectiveness

Curing rare childhood diseases will falter unless Congress steps up

Bird flu: Don't repeat Covid's 'health versus the economy' framing

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

focus

hotspot

knowledge

explore